MiR-96-5p is an oncogene in lung adenocarcinoma and facilitates tumor progression through ARHGAP6 downregulation
Authors:
- 2 August 2021
- journal article
- research article
- Published by Springer Nature in Journal of Applied Genetics
- Vol. 62 (4) , 631-638
Abstract
Accumulating investigations illustrated that miRNA acts as a key regulator in tumor progression, whereas regulatory role of miR-96-5p in lung adenocarcinoma (LUAD) is warranted. Thus, we sought to probe mechanism of miR-96-5p in this disease. Through bioinformatics analysis, miR-96-5p level in normal tissue and LUAD tissue in TCGA database were obtained. Meanwhile, mRNA expression dataset was analyzed to obtain downregulated mRNAs binding to miR-96-5p. qRT-PCR assessed miR-96-5p and ARHGAP6 mRNA in LUAD. Western blot assessed protein level of ARHGAP6 in LUAD. Dual-luciferase reporter gene detection verified targeting relationship of miR-96-5p and ARHGAP6. Biological functional experiments such as CCK-8, colony formation, scratch healing, and Transwell assessed cell proliferation, migration, and invasion. MiR-96-5p was overexpressed, which fostered LUAD cell proliferation, migration, and invasion. ARHGAP6 was downregulated in LUAD and targeted by miR-96-5p. ARHGAP6 upregulation prominently restored promotion of miR-96-5p on cell progression. MiR-96-5p could stimulate LUAD progression through targeting ARHGAP6. This study generates a novel direction and lays a theoretical basis for targeted therapy.Keywords
Funding Information
- 2020 Zhejiang Medical and health science and Technology Program (2020KY053)
- Zhejiang Lung Cancer center
This publication has 19 references indexed in Scilit:
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung CancerNew England Journal of Medicine, 2019
- ARHGAP6 regulates the proliferation, migration and invasion of lung cancer cellsOncology Reports, 2019
- Targeting of SGK1 by miR-576-3p Inhibits Lung Adenocarcinoma Migration and InvasionMolecular Cancer Research, 2019
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methodsInternational Journal of Cancer, 2018
- miR‐297 acts as an oncogene by targeting GPC5 in lung adenocarcinomaCell Proliferation, 2016
- Inhibitory effects of Arhgap6 on cervical carcinoma cellsTumor Biology, 2015
- Genomic alterations in lung adenocarcinomaThe Lancet Oncology, 2015
- Screening and early detection efforts in lung cancerCancer, 2015
- Immunotherapy for Lung Cancer: Has it Finally Arrived?Frontiers in Oncology, 2014
- Functional analysis of ARHGAP6, a novel GTPase-activating protein for RhoAHuman Molecular Genetics, 2000